﻿<?xml version="1.0" encoding="UTF-8"?>
<records>
  <record>
    <language>eng</language>
    <publisher>Science and Education Publishing</publisher>
    <journalTitle>International Journal of Celiac Disease</journalTitle>
    <eissn>2334-3486</eissn>
    <publicationDate>2021-01-21</publicationDate>
    <volume>9</volume>
    <issue>1</issue>
    <startPage>6</startPage>
    <endPage>9</endPage>
    <doi>10.12691/ijcd-9-1-8</doi>
    <publisherRecordId>IJCD2021918</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">The COVID-19 Vaccination Debate: CoV-2 in Celiac Disease: A Pathogen or just along for the Ride?</title>
    <authors>
      <author>
        <name>Aaron Lerner</name>
        <email>aaronlerner1948@gmail.com</email>
        <affiliationId>1</affiliationId>
      </author>
    </authors>
    <affiliationsList>
      <affiliationName affiliationId="1">Chaim Sheba Medical Center, the Zabludowicz Center for Autoimmune Diseases, Tel-Hashomer, Israel</affiliationName>
    </affiliationsList>
    <abstract language="eng">SARS-CoV-2, the virus that causes COVID-19, impacts human health all over the world with high morbidity and mortality. Many chronic diseases predispose the patients to be infected, including autoimmune diseases. Despite theoretical and rare exceptions, celiac disease is not a high-risk condition for COVID-19 infection. The present review expends on those potential circumstances that put the CD patients at risk for COVID-19.</abstract>
    <fullTextUrl format="pdf">http://pubs.sciepub.com/ijcd/9/1/8/ijcd-9-1-8.pdf</fullTextUrl>
    <keywords language="eng">
      <keyword>celiac disease</keyword>
      <keyword>Coronavirus 2</keyword>
      <keyword>SARS-CoV-2</keyword>
      <keyword>COVID-19</keyword>
      <keyword>risk</keyword>
    </keywords>
  </record>
</records>